Sign in
Stories
Brainstorm Cell Therapeutics Faces Securities Class Action
Share
AlloVir Faces Class Action Allegations
AlloVir Faces Class Action Lawsuit
AlloVir Faces Lawsuit Over Statements
BCLI Facing Securities Class Action
Kenvue Faces Lawsuit Over False Claims
Kessler Topaz Meltzer & Check, LLP Files...
Overview
API
Rosen Law Firm is urging Brainstorm Cell Therapeutics Inc. investors to participate in a securities class action lawsuit due to alleged false and misleading statements by the company's defendants. The firm emphasizes its experience in securities class action settlements and highlights the severity of the U.S. Food and Drug Administration's refusal to file letter and concealed risks associated with the submission of the biologics license application, leading to investor damages.
Ask a question
How does the involvement of a leading trial attorney firm like Rosen Law Firm influence the outcome of securities class action lawsuits?
How might the outcome of this securities class action impact the reputation and financial standing of Brainstorm Cell Therapeutics Inc.?
What measures can companies take to avoid false and misleading statements in financial disclosures?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Dec 2023
Coverage